These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3154698)

  • 1. Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?
    Caralis DG; Kyriakides Z
    Cardiovasc Drugs Ther; 1988 May; 2(1):79-82. PubMed ID: 3154698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.
    Kyriakidis M; Vyssoulis G; Sfikakis P; Kyriakidis C; Pitsavos C; Valsamis K; Nomikos V; Toutouzas P
    Eur J Clin Pharmacol; 1989; 37(5):443-7. PubMed ID: 2598982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems in acute therapy of coronary heart disease using drugs that reduce preload and afterload].
    Krüger R
    Med Klin (Munich); 1987 Jan; 1():19-23. PubMed ID: 3106750
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
    Schartl M; Dougherty C; Rutsch W; Schmutzler H
    Am Heart J; 1985 Mar; 109(3 Pt 2):649-53. PubMed ID: 3838401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
    Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
    Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of oral molsidomine and nifedipine on methylergometrine-induced coronary artery spasm.
    Danchin N; Juillière Y; Anconina J; Perrin O; Selton-Suty C; Cherrier F
    Am J Cardiol; 1991 Jun; 67(15):1208-11. PubMed ID: 2035442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in haemodynamics and left ventricular function during intravenous nifedipine infusion with and without additional propranolol in patients with coronary artery disease. A randomized, placebo controlled trial.
    Mauser M; Voelker W; Roser D; Karsch KR; Seipel L
    Eur J Clin Pharmacol; 1987; 33(4):345-8. PubMed ID: 3327697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molsidomine in the treatment of coronary insufficiency].
    Weber S
    Rev Med Interne; 1987; 8(4):437-43. PubMed ID: 2892240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of nifedipine in patients with ischemic heart disease.
    Majid PA; De Jong J
    Circulation; 1982 Jun; 65(6):1114-8. PubMed ID: 7074773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.
    Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
    Mauser M; Voelker W; Karsch KR
    Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of molsidomine on pulmonary artery pressure and work capacity in patients with coronary heart disease.
    Jansen W; Eggeling T; Meyer L; Tauchert M; Hilger HH
    Eur Heart J; 1987 Aug; 8(8):870-7. PubMed ID: 3665944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of intracoronary nifedipine during percutaneous transluminal coronary angioplasty.
    Hombach V; Höpp HW; Fuchs M; Behrenbeck DW; Tauchert M; Hilger HH
    Herz; 1986 Aug; 11(4):232-6. PubMed ID: 2944807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy.
    Percy RF; Bass TA; Conetta DA; Miller AB
    Clin Cardiol; 1989 Aug; 12(8):435-40. PubMed ID: 2766589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salutary effect of nifedipine in pacing-induced angina: relation to afterload reduction.
    Tiefenbrunn AJ; Sobel BE; Ludbrook PA
    Cathet Cardiovasc Diagn; 1983; 9(6):583-9. PubMed ID: 6661773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molsidomine: alternative approaches to treat myocardial ischemia.
    Nitz RE; Fiedler VB
    Pharmacotherapy; 1987; 7(1):28-37. PubMed ID: 3554158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy.
    Caralis DG; Kyriakides Z; Ioakimides C
    Cardiovasc Drugs Ther; 1991 Feb; 5(1):155-6. PubMed ID: 2036334
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.